A dominant area of antibody research is the extension of the use of this mighty experimental
and therapeutic tool for the specific detection of molecules for diagnostics, visualization, and …

Catalytic antibodies made it feasible to develop new catalysts, which had previously been
the subject of research. Scientists have discovered natural antibodies that can hydrolyze …

The tetraiodothyroacetic acid (tetrac) component of nano-diamino-tetrac (NDAT) is
chemically bonded via a linker to a poly (lactic-co-glycolic acid) nanoparticle that can …

The use of antibodies as targeting molecules or cell-penetrating tools has emerged at the
forefront of pharmaceutical research. Antibody-directed therapies in the form of antibody …

Some antinuclear antibodies (ANAs) bind extracellular nucleic acids released into tumor
environments and are pulled into the nuclei of live cancer cells through nucleoside salvage …

Therapeutic antibodies have revolutionized modern medicine. At present, antibodies are
successfully used for treatment of diverse human diseases, ranging from cancer to viral …

A key challenge in the development of novel chemotherapeutics is the design of molecules
capable of selective toxicity to cancer cells. Antibodies have greater target specificity …

Previous studies have shown that focused ultrasound (FUS) combined with systematic
administration of microbubbles (MBs) can open the blood brain barrier (BBB) locally …

The blood-brain barrier (BBB) prevents antibodies from penetrating the CNS and limits
conventional antibody-based approaches to brain tumors. We now show that ENT2, a …

Nuclear-penetrating anti-DNA autoantibodies have therapeutic potential as delivery agents
and in targeting DNA and the DNA damage response (DDR). Derivatives of such Abs have …